Aim: We present a fatal case of congenital herpes simplex virus (HSV) infection following exposure of a non-immune mother by her partner during critical fetal development.
Background: Globally, neonatal HSV infection affects 1 in 10,000 births. The most common mode of transmission is perinatally through passage through the vaginal canal (85%), followed by postnatal acquisition (10%). Rarely, intrauterine infection can occur (5%) resulting in congenital HSV, presenting with a classic triad of skin desquamation, chorioretinitis and brain malformations including hydrocephaly, anencephaly, and porencephaly.
Case description: A 30-week pregnant woman with a history of flu-like illness at 18 weeks presented with decreased fetal movement and vaginal bleeding. Initial evaluation showed echogenic bowel on ultrasound. At 30 weeks, polyhydramnios and fetal brain abnormalities were noted. A c-section was performed, and the infant required resuscitation. The infant's father reported a history of genital HSV outbreaks and HSV-2 was detected in the infant's blood. The infant had extensive skin desquamation, seizures, and succumbed to fatal brain malformations.
Conclusion: While maternal treatment with antiviral medication and cesarean section are effective in preventing perinatal HSV infection, congenital infection in the first or second trimester of pregnancy with devastating consequences for the fetus can occur in women without HSV immunity.
Clinical significance: Given the lack of available HSV immunization, protection of non-immune pregnant individuals from HSV exposure is currently the only preventive measure against congenital HSV disease.
James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: Global infection prevalence and incidence estimates, 2016. Bull World Health Organ 2020;98(5):315–329. DOI: 10.2471/BLT.19.237149.
Krishnan R, Stuart PM. Developments in vaccination for herpes simplex virus. Front Microbiol 2021;12:798927. DOI: 10.3389/fmicb.2021.798927.
Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009;361(14):1376–1385. DOI: 10.1056/NEJMra0807633.
Corey L, Whitley RJ, Stone EF, et al. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988;1(8575-6):1–4. DOI: 10.1016/s0140-6736(88)90997-x.
Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324(7):450–454. DOI: 10.1056/NEJM199102143240704.
Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001;108(2):223–229. DOI: 10.1542/peds.108.2.223.
Cleary KL, Pare E, Stamilio D, et al. Type-specific screening for asymptomatic herpes infection in pregnancy: A decision analysis. BJOG 2005;112(6):731–736. DOI: 10.1111/j.1471-0528.2005.00540.x.
Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337(8):509–515. DOI: 10.1056/NEJM199708213370801.
Fa F, Laup L, Mandelbrot L, et al. Fetal and neonatal abnormalities due to congenital herpes simplex virus infection: A literature review. Prenat Diagn 2020;40(4):408–414. DOI: 10.1002/pd.5587.
Pithadia DJ, Kerns ML, Golden WC, et al. Heterogeneous cutaneous findings associated with intrauterine HSV infection: A case series and literature review. Pediatr Dermatol 2021;38(4): 831–841. DOI: 10.1111/pde.14682.
O‘Riordan DP, Golden WC, Aucott SW. Herpes simplex virus infections in preterm infants. Pediatrics 2006;118(6):e1612–e1620. DOI: 10.1542/peds.2005-1228.
Pichler M, Staffler A, Bonometti N, et al. Premature newborns with fatal intrauterine herpes simplex virus-1 infection: First report of twins and review of the literature. J Eur Acad Dermatol Venereol 2015;29(6):1216–1220. DOI: 10.1111/jdv.12583.
Deftereou TE, Trypidi A, Alexiadi CA, et al. Congenital herpes simplex virus: A histopathological view of the placenta. Cureus 2022;14(9):e29101. DOI: 10.7759/cureus.29101.
Van Wagoner N, Qushair F, Johnston C. Genital herpes infection: Progress and problems. Infect Dis Clin North Am 2023;37(2):351–367. DOI: 10.1016/j.idc.2023.02.011.
Urato AC. ACOG Practice Bulletin No. 220: Management of Genital Herpes in Pregnancy. Obstet Gynecol. 2020;136(4):850–851. DOI: 10.1097/AOG.0000000000004115.
Backes IM, Leib DA, Ackerman ME. Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections. Front Immunol 2022;13:959603. DOI: 10.3389/fimmu.2022.959603.
Patel CD, Backes IM, Taylor SA, et al. Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity. Sci Transl Med 2019;11(487). DOI: 10.1126/scitranslmed.aau6039.